Subject Areas on Research
- A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
- A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.
- A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis.
- Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.
- Biphasic malignant meningioma: a comparative genomic hybridization study.
- Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation.
- Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.
- Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.
- Comparison of diagnostic markers with repeated measurements: a non-parametric ROC curve approach.
- Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
- Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.
- Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese population.
- Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities.
- Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.
- Limited effects of Muc1 deficiency on mouse adenovirus type 1 respiratory infection.
- MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.
- Meningioma of the fourth ventricle.
- Myolipoma of the eyelid.
- Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
- Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.
- Surface structure of human mucin using X-ray photoelectron spectroscopy.
- Technology evaluation: BLP-25, Biomira Inc.
Keywords of People
- Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology